文献速递肝胆胰外科急腹症与外科感染围术期管理与 ERAS

重新审视七日规则:急性胆囊炎腹腔镜胆囊切除术的国际回顾性分析

Revisiting the seven-day rule: an international retrospective analysis of laparoscopic cholecystectomy for acute cholecystitis.
PubMed 文献 · Surg Endosc · 2026-05-04

这项国际回顾性队列纳入1421例急性结石性胆囊炎行早期腹腔镜胆囊切除术的患者,按症状持续时间分为≤7天组(1312例)和>7天组(109例)。多变量分析显示两组在主要并发症、中转开腹和手术时间上无显著差异,>7天组术后住院时间更短但敏感性分析未达统计学显著。结论认为在经验丰富的中心,超过7天手术是安全的,七日阈值必要性受到挑战。

要点

  • 症状>7天组与≤7天组主要并发症、中转开腹、手术时间无显著差异。
  • >7天组术后住院时间中位数1天,调整率比0.80(95%CI 0.65-0.97),敏感性分析未显著。
  • 经验丰富中心可考虑对症状超过7天的患者行早期腹腔镜胆囊切除术。

核心结论

  • 症状发作超过7天行腹腔镜胆囊切除术是安全的,结局与症状持续时间较短的患者相当。
  • 这些发现挑战了在经验丰富中心沿用七日阈值的必要性。
  • 需要随机试验来确定对症状持续较长的患者早期手术是否优于保守治疗。

研究设计与样本

  • 国际回顾性队列研究,纳入两家高容量中心2015年至2021年因急性结石性胆囊炎行早期腹腔镜胆囊切除术的患者。
  • 共纳入1421例患者,按症状持续时间分为≤7天组(1312例,92%)和>7天组(109例,8%)。
  • 采用多变量分析比较主要并发症、中转开腹、手术时间和术后住院时间。

主要发现

  • 主要并发症在≤7天组为7.9%,>7天组为5.5%(调整OR 0.88,95%CI 0.36-2.14),无显著差异。
  • 中转开腹在≤7天组为3.4%,>7天组为2.8%(调整OR 0.77,95%CI 0.23-2.56),无显著差异。
  • 中位手术时间≤7天组为73分钟,>7天组为78分钟(调整几何均值比0.97;95%CI 0.90-1.05),无显著差异。
  • 术后住院时间>7天组更短(中位数1天[IQR 1-2] vs 1天[IQR 1-2];调整率比0.80,95%CI 0.65-0.97),但排除离群值的敏感性分析中差异未达统计学显著。

临床怎么用

  • 在经验丰富的中心,不应仅因症状超过7天而延迟腹腔镜胆囊切除术。
  • 对症状超过7天的急性结石性胆囊炎患者,可考虑行早期腹腔镜胆囊切除术。
  • 需个体化评估,并结合本中心经验与资源决定手术时机。

局限性

  • 为回顾性队列研究,存在选择偏倚和混杂因素可能。
  • >7天组样本量较小(109例),可能影响统计效能。
  • 术后住院时间差异在排除离群值的敏感性分析中未达统计学显著。
  • 研究在两家高容量中心进行,结果外推至经验较少中心需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although early laparoscopic cholecystectomy is the gold standard for acute calculous cholecystitis, its safety in patients presenting more than seven days after symptom onset remains debated. Concerns over increased surgical difficulty and complication rates often results in delaying cholecystectomy, yet evidence supporting this seven-day threshold is lacking. Therefore, this study evaluated the safety of early laparoscopic cholecystectomy in patients operated within versus beyond seven days of symptom onset. METHODS: This international retrospective cohort included patients who underwent early laparoscopic cholecystectomy for acute calculous cholecystitis at two high-volume centers between 2015 and 2021. Patients were categorized by symptom duration: ≤ 7 days or > 7 days. Multivariable analyses compared major complications (bile duct injury/leakage, bowel injury, bleeding, or postoperative complication Clavien-Dindo grade ≥ 3a), conversions, operative time, and postoperative hospital stay. RESULTS: A total of 1421 patients were included. Of these, 1312 patients (92%) had ≤ 7 days of symptoms, and 109 (8%) > 7 days. There were no significant differences in major complications, conversion to open surgery, or operative time. Major complications occurred in 7.9% of the ≤ 7 days group vs 5.5% of the > 7 days group (adjusted OR 0.88, 95% CI 0.36-2.14), conversion to open surgery in 3.4% vs 2.8% (adjusted OR 0.77, 95% CI 0.23-2.56), and median operative time was 73 vs 78 min (adjusted geometric mean ratio 0.97; 95% CI 0.90-1.05). Postoperative hospital stay was shorter in the > 7 days group (median 1 [IQR 1-2] vs 1 [IQR 1-2] days; adjusted rate ratio 0.80, 95% CI 0.65-0.97), although this difference was not statistically significant in a sensitivity analysis excluding outliers. CONCLUSION: Laparoscopic cholecystectomy performed beyond seven days from symptom onset was safe, with outcomes comparable to patients with a shorter symptom duration. These findings challenge the necessity of the seven-day threshold in experienced centers. A randomized trial is warranted to determine whether early surgery offers advantages over conservative treatment in patients with prolonged symptoms.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. van Maasakkers MHG, Meij SEF, Lim Y, et al. Revisiting the seven-day rule: an international retrospective analysis of laparoscopic cholecystectomy for acute cholecystitis. Surg Endosc. 2026. PMID: 42257968. doi:10.1007/s00464-026-12788-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。